Ross Moat Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Ross Moat is CHIEF CORP. & COMM. OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 9,415 shares of KNSA, which is worth approximately $379,612. The most recent transaction as insider was on Mar 21, 2022, when has been sold 2,270 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.42K
0% 3M change
56.68% 12M change
Total Value Held $379,612

Ross Moat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
2,270 Added 20.86%
8,612 Class A Common Share
Mar 16 2022
SELL
Payment of exercise price or tax liability
$5,511 $10.13 p/Share
544 Reduced 7.9%
6,342 Class A Common Share
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
995 Added 12.63%
6,886 Class A Common Share
Jan 15 2022
BUY
Grant, award, or other acquisition
$14,888 $9.63 p/Share
1,546 Added 20.79%
5,891 Class A Common Share
Jul 15 2021
BUY
Grant, award, or other acquisition
$11,065 $11.49 p/Share
963 Added 18.14%
4,345 Class A Common Share
RM

Ross Moat

CHIEF CORP. & COMM. OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA